Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Dexa Medica Group clinical trials
Also known as DLBS.
The registry lists 41 studies whose lead sponsor is Dexa Medica Group. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 19, 2026.
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Dexa Medica Group.
- Dexa Medica Group41 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 41 of 41.
- The Efficacy and Safety of Reconyl in Acute Cough TreatmentCompletedNCT07420491Phase 3
- DLBS2411 Treatment For Functional DyspepsiaCompletedNCT05248802Phase 3
- Supplementation of Galatonol 300 mg / Striatin 30 mg in Postpartum Lactating MothersCompletedNCT06558071Phase 3
- Bioequivalence Study of Apixaban 5 mg Film-Coated TabletCompletedNCT06817811Phase 1
- Safety and Efficacy Reconyl for Cough With/Without Sore ThroatCompletedNCT06510257Phase 2
- Safety and Efficacy Predimenol for HeadacheCompletedNCT06558006Phase 2
- Efficacy and Safety of Silfamin for Common ColdCompletedNCT06497439Phase 2
- Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT06127225Phase 2
- Bioequivalence Study of Rivaroxaban 10 mg Film-coated TabletsCompletedNCT06558058Phase 1
- Bioequivalence Study of Tamsulosin 0.4 mg Sustained Release Film-coated TabletsCompletedNCT06558032Phase 1
- Bioequivalence Study of Rivaroxaban 20 mg Film-coated TabletsCompletedNCT06558045Phase 1
- DLBS1033 for Acute Ischemic Stroke PatientsTerminatedNCT02133521Phase 2/3
- Bioequivalence Study of Dapagliflozin 10 mg Film-coated TabletsCompletedNCT06127212Not applicable
- Effect of DLBS1033 After Primary PCI in Patients With STE-ACSTerminatedNCT02976701Phase 2/3
- DLBS1442 for The Treatment of Pain in Patients Suspected EndometriosisCompletedNCT01942122Phase 2/3
- Efficacy and Safety of DLBS2411 in the Management of GERDTerminatedNCT03367195Phase 3
- DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic UlcersTerminatedNCT02262169Phase 3
- PCOS Treatment Using DLBS3233, Metformin, and Combination of BothCompletedNCT01999686Phase 3
- Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)CompletedNCT01733459Phase 3
- DLBS1033 Treatment in Diabetic With Peripheral Arterial DiseaseTerminatedNCT02145988Phase 2/3
- Bioequivalence Study of 120 mg Etoricoxib Film-coated TabletsCompletedNCT03422575Not applicable
- DLBS1033 for the Treatment of Acute Ischemic StrokeTerminatedNCT02362984Phase 3
- Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes MellitusCompletedNCT01865474Phase 4
- DLBS1449 in Diabetic Patients With Low HDLWithdrawnNCT01972477Phase 2/3
- DLBS1033 for Acute NSTEMI Without Early Coronary RevascularizationWithdrawnNCT02146664Phase 2/3
- Bioequivalence Study of Two Formulations of Pramipexole Tablets 0.25 mgCompletedNCT02660060Not applicable
- Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mgCompletedNCT02518451Not applicable
- Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes MellitusCompletedNCT01645332Phase 3
- Bioequivalence Study of Two Formulations of Pregabalin Capsules 150 mgCompletedNCT02233777Not applicable
- Efficacy of DLBS1033 in Patients With Acute Ischemic StrokeCompletedNCT01790997Phase 3
- Bioequivalence Study of Two Formulations of 10 mg Lisinopril Tablet Under Fasting ConditionCompletedNCT01936012Not applicable
- Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes MellitusCompletedNCT01472614Phase 3
- Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer PatientsCompletedNCT01433562Phase 2/3
- Efficacy and Safety of DLBS2411 in Healthy VolunteersCompletedNCT01573403Phase 1/2
- Efficacy and Safety of DLBS1425 in Subjects With Advanced/Metastatic Breast CancerTerminatedNCT01006785Phase 2
- Bioequivalence Study of Two Formulations of Perindopril 4 mg Tablet Under Fasting ConditionCompletedNCT01682577Not applicable
- Bioequivalence Study of Two Formulations of 500 mg Metformin Extended Release TabletCompletedNCT01677260Not applicable
- Bioequivalence Study of 4 mg Glimepiride TabletCompletedNCT01677247Not applicable
- Safety and Efficacy of DLBS1033 in Healthy SubjectsCompletedNCT01378585Not applicable
- Efficacy and Safety of DLBS3233 in Prediabetic PatientsCompletedNCT01531933Phase 3
- Efficacy of DLBS-32 in Subjects With Type-II Diabetes MellitusCompletedNCT01005069Phase 2